Literature DB >> 7684178

Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.

M Higuchi1, T Ohnishi, N Arita, S Hiraga, T Hayakawa.   

Abstract

The immunohistochemical distribution of tenascin (TN), fibronectin (FN), and laminin (LN) was investigated in 56 human gliomas (8 astrocytomas, 15 anaplastic astrocytomas, and 33 glioblastomas) with regards to the histological degree of malignancy and the degree of tumor cell differentiation evaluated by the staining of glial fibrillary acidic protein (GFAP). In 8 anaplastic astrocytomas and 28 glioblastomas, TN was predominantly immunolocalized in the basement membrane zone of the proliferating tumor vessels; sections of all astrocytomas were negative for TN staining. FN was localized in the basement membrane zone of the vessels in all astrocytomas, 12 anaplastic astrocytomas, and 22 glioblastomas. In 7 anaplastic astrocytomas and 19 glioblastomas, both TN and FN were expressed to various degrees in the tumor vessels. However, most of the TN-positive vessels did not express FN, and most of the FN-positive vessels were negative for TN staining. Furthermore, in 6 anaplastic astrocytomas and 12 glioblastomas, either TN or FN, but not both, were expressed in any area on serial sections. Most of the tumor cells around TN-positive, FN-negative tumor vessels did not express GFAP. On the other hand, GFAP was present in most tumor cells around TN-negative, FN-positive vessels. LN was detected in all vascular and pial-glial basement membrane zone of the tissues examined. These findings indicate that the degree of histological malignancy and the degree of cell dedifferentiation of human gliomas correlate well with the expression of TN, but are inversely correlated with the expression of FN.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684178     DOI: 10.1007/bf00230486

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

1.  Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus.

Authors:  A Vaheri; E Ruoslahti
Journal:  Int J Cancer       Date:  1974-05-15       Impact factor: 7.396

2.  Distribution of extracellular matrix proteins in primary human brain tumours: an immunohistochemical analysis.

Authors:  J T Rutka; C A Myatt; J R Giblin; R L Davis; M L Rosenblum
Journal:  Can J Neurol Sci       Date:  1987-02       Impact factor: 2.104

3.  The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia.

Authors:  R Anbazhagan; T Sakakura; B A Gusterson
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

4.  A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen.

Authors:  F S Jones; M P Burgoon; S Hoffman; K L Crossin; B A Cunningham; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions.

Authors:  E Aufderheide; P Ekblom
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

6.  Tenascin mediates cell attachment through an RGD-dependent receptor.

Authors:  M A Bourdon; E Ruoslahti
Journal:  J Cell Biol       Date:  1989-03       Impact factor: 10.539

7.  Induction of tenascin in healing wounds.

Authors:  E J Mackie; W Halfter; D Liverani
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

8.  Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro.

Authors:  E J Mackie; I Thesleff; R Chiquet-Ehrismann
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

9.  Increased levels of type VIII collagen in human brain tumours compared to normal brain tissue and non-neoplastic cerebral disorders.

Authors:  W Paulus; E H Sage; U Liszka; M L Iruela-Arispe; K Jellinger
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

10.  Changes in the distribution of tenascin during tooth development.

Authors:  I Thesleff; E Mackie; S Vainio; R Chiquet-Ehrismann
Journal:  Development       Date:  1987-10       Impact factor: 6.868

View more
  25 in total

1.  Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions.

Authors:  H Bouterfa; A R Darlapp; E Klein; T Pietsch; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas.

Authors:  B Oz; F A Karayel; N L Gazio; F Ozlen; K Balci
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 3.  Angiogenesis in brain tumors; pathobiological and clinical aspects.

Authors:  P Wesseling; D J Ruiter; P C Burger
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

Review 4.  Tenascins and the importance of adhesion modulation.

Authors:  Ruth Chiquet-Ehrismann; Richard P Tucker
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

Review 5.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

6.  Tenascin distribution in human brain tumours.

Authors:  P Castellani; A Dorcaratto; A Siri; L Zardi; G L Viale
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Expression of type VII collagen, the major anchoring fibril component, in normal and neoplastic human nervous system.

Authors:  W Paulus; I Baur; U Liszka; M Drlicek; I Leigh; L Bruckner-Tuderman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 8.  Anti-angiogenic gene therapy in the treatment of malignant gliomas.

Authors:  NaTosha N Gatson; E Antonio Chiocca; Balveen Kaur
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

Review 9.  Interactions of glioma cells and extracellular matrix.

Authors:  W Paulus; J C Tonn
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Tenascin-R is antiadhesive for activated microglia that induce downregulation of the protein after peripheral nerve injury: a new role in neuronal protection.

Authors:  D N Angelov; M Walther; M Streppel; O Guntinas-Lichius; W F Neiss; R Probstmeier; P Pesheva
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.